Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential

por Hourani, Wafa, Alexander, Stephen P. H.
Publicado 2018

Molecular and metabolic alterations of 2,3-dihydroquinazolin-4(1H)-one derivatives in prostate cancer cell lines

por Dahabiyeh, Lina A., Hourani, Wafa, Darwish, Wesam, Hudaib, Farah, Abu-Irmaileh, Bashaer, Deb, Pran Kishore, Venugopala, Katharigatta N., Mohanlall, Viresh, Abu-Dahab, Rana, Semreen, Mohammad H., Bustanji, Yasser
Publicado 2022

Effect of IFN‑γ encapsulated liposomes on major signal transduction pathways in the lymphocytes of patients with lung cancer

por Alhawamdeh, Maysa, Almajali, Belal, Hourani, Wafa, Al-Jamal, Hamid Ali Nagi, Al-Wajeeh, Abdullah Saleh, Mwafi, Nesrin Riad, Al-Hajaya, Yousef, Saad, Hanan Kamel M., Anderson, Diana, Odeh, Mahmoud, Tarawneh, Ibraheam A.
Publicado 2023

Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives

por Venugopala, Katharigatta N., Al-Shar’i, Nizar A., Dahabiyeh, Lina A., Hourani, Wafa, Deb, Pran Kishore, Pillay, Melendhran, Abu-Irmaileh, Bashaer, Bustanji, Yasser, Chandrashekharappa, Sandeep, Tratrat, Christophe, Attimarad, Mahesh, Nair, Anroop B., Sreeharsha, Nagaraja, Shinu, Pottathil, Haroun, Michelyne, Kandeel, Mahmoud, Balgoname, Abdulmalek Ahmed, Venugopala, Rashmi, Morsy, Mohamed A.
Publicado 2022

Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme

por Venugopala, Katharigatta N., Chandrashekharappa, Sandeep, Deb, Pran Kishore, Tratrat, Christophe, Pillay, Melendhran, Chopra, Deepak, Al-Shar’i, Nizar A., Hourani, Wafa, Dahabiyeh, Lina A., Borah, Pobitra, Nagdeve, Rahul D., Nayak, Susanta K., Padmashali, Basavaraj, Morsy, Mohamed A., Aldhubiab, Bandar E., Attimarad, Mahesh, Nair, Anroop B., Sreeharsha, Nagaraja, Haroun, Michelyne, Shashikanth, Sheena, Mohanlall, Viresh, Mailavaram, Raghuprasad
Publicado 2021